000 | 01076 a2200289 4500 | ||
---|---|---|---|
005 | 20250512205646.0 | ||
264 | 0 | _c19830923 | |
008 | 198309s 0 0 eng d | ||
022 | _a0360-3016 | ||
024 | 7 |
_a10.1016/0360-3016(83)90194-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDenekamp, J | |
245 | 0 | 0 |
_aIs the outlook grey for WR-2721 as a clinical radioprotector? _h[electronic resource] |
260 |
_bInternational journal of radiation oncology, biology, physics _cAug 1983 |
||
300 |
_a1247-9 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aAmifostine _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xradiotherapy |
650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xtherapeutic use |
650 | 0 | 4 |
_aRadiation-Protective Agents _xtherapeutic use |
700 | 1 | _aStewart, F A | |
700 | 1 | _aRojas, A | |
773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 9 _gno. 8 _gp. 1247-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0360-3016(83)90194-3 _zAvailable from publisher's website |
999 |
_c6307866 _d6307866 |